1984
DOI: 10.1016/0167-0115(84)90034-x
|View full text |Cite
|
Sign up to set email alerts
|

Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
57
2
1

Year Published

1989
1989
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 180 publications
(63 citation statements)
references
References 18 publications
3
57
2
1
Order By: Relevance
“…In response to feeding, PYY and GLP-1 are both secreted from endocrine L-cells of the distal ileum and colon (Bottcher et al 1984) and PP, a member of the PP-fold peptide family, which also includes PYY and neuropeptide Y (NPY), is produced by endocrine type F-cells of the pancreatic islets (Adrian et al 1976). These satiety hormones seem to inhibit food intake by altering central nervous system appetite circuits, within the arcuate nucleus of the hypothalamus or area postrema (Gutzwiller et al 1999.…”
Section: Discussionmentioning
confidence: 99%
“…In response to feeding, PYY and GLP-1 are both secreted from endocrine L-cells of the distal ileum and colon (Bottcher et al 1984) and PP, a member of the PP-fold peptide family, which also includes PYY and neuropeptide Y (NPY), is produced by endocrine type F-cells of the pancreatic islets (Adrian et al 1976). These satiety hormones seem to inhibit food intake by altering central nervous system appetite circuits, within the arcuate nucleus of the hypothalamus or area postrema (Gutzwiller et al 1999.…”
Section: Discussionmentioning
confidence: 99%
“…NPY is widely distributed in the peripheral nervous system and is co-localized with noradrenaline (NA) in many sympathetic fibres (Lundberg et al, 1982b), notably around blood vessels (Uddman et al, 1985). PYY in contrast occurs mainly in endocrine cells in the gut (Lundberg et al, 1982a;Bottcher et al, 1984). NPY has been attributed a variety of functional roles (for a review see Edvinsson et al, 1987).…”
Section: Introductionmentioning
confidence: 99%
“…85,88,81,94,95,91 This result may explain the improvements in the clinical and laboratorial conditions of patients with metabolic syndrome who undergo these procedures.…”
Section: After Ileal Interpositionmentioning
confidence: 83%